You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
12 August 2026 - Swedish pharmaceutical company EQL Pharma AB (STO: EQL) announced on Wednesday that it has licensed its methenamine hippurate product Memprex for sale in Hungary through local pharmaceutical company Pharmacenter, which develops and c...
12 August 2026 - Cell-free DNA and precision medicine company Natera Inc (NASDAQ:NTRA) said on Wednesday that it will provide its Latitude tissue-free molecular residual disease (MRD) assay for a Phase 1 clinical trial sponsored by Kupando Therapeuti...
12 August 2026 - Swedish biotech company AlzeCure Pharma AB (FN STO:ALZCUR) announced on Wednesday that it has received the full USD12m upfront payment from Danish biotech company QuantumCell ApS under their licensing and collaboration agreement for ...
12 August 2026 - Graviton BioScience Corporation, a privately held, clinical-stage biotechnology company developing a diverse pipeline of therapeutics, including selective ROCK2 inhibitors for metabolic, inflammatory, fibrotic, and central nervous sy...
12 August 2026 - Galvanize Therapeutics Inc, a commercial-stage medical technology company focused on pulsed electric field (PEF) therapies for oncology and chronic lung disease, announced on Tuesday the completion of the first commercial procedures ...
12 August 2026 - Chinese biotechnology company Laekna (HK:2105) announced on Tuesday that the New Drug Application (NDA) for LAE002 (afuresertib) has been accepted by the Center for Drug Evaluation (CDE) of China's National Medical Products Admi...
11 August 2026 - Italian pharmaceutical company Alfasigma S.p.A. announced on Tuesday that it has entered into an agreement with SEVER Life Sciences B.V. to acquire 100% of Nordic Group B.V. and its subsidiaries, expanding its specialty pharmaceutica...